Radient Pharmaceuticals Corporation (Amex: RPC) 115.7% HIGHER; announced the monoclonal antibody test that the company began working on twenty years ago and that the FDA and many other international agencies have approved, may change how people screen for early cancer detection. Radient’s Onko-Sure in vitro diagnostic test enables physicians and their patients to effectively monitor and/or detect solid tumor cancers. Click here to see more details from the release.
Compellent Technologies (NYSE: CML) 24.7% LOWER; lowers its Q1 sales guidance from $35-$37 million to $31.5-$32 million. The Street is currently looking for quarterly sales of $36.37 million. The stock was also downgraded at Merriman, Needham and Northland Securities.
Streamline Health Solutions, Inc. (Nasdaq: STRM) 24.3% HIGHER; reports Q4 EPS of $0.17, 1 cent better than the analyst estimate of $0.16. Revenue for the quarter was $6.3 million, which compares to the estimate of $6.28 million. (only 1 analyst on the stock)
PGT, Inc. (Nasdaq: PGTI) 22.3% HIGHER; after clearing the $2 level yesterday, shares are continuing higher today. Volume remains very heavy. Shares have not held of this price level since January.
Zep, Inc. (NYSE: ZEP) 18.4% LOWER; reports Q2 adjusted EPS of $0.09, versus the analyst estimate of $0.13. Revenue for the quarter was $127.4 million, which compares to the estimate of $128.81 million.
A.C. Moore Arts & Crafts (Nasdaq: ACMR) 17.6% HIGHER; Wedbush upgrades the stock from Underperform to Outperform. Price target increased to $6.
First Bancorp (NYSE: FBP) 16% LOWER; traders are likely taking profits today following 3 straight days of upside in which the stock gained nearly 50%. Volume has been extremely heavy recently, and remains that way today.
Core Molding Technologies Inc. (AMEX: CMT) 15.7% HIGHER; reports Q4 EPS of $0.25, versus $0.20 reported for the same period a year ago. Revenue for the quarter was $23.23 million, compared to $27.60 million in Q408.
Tongjitang Chinese Medicines Company (NYSE: TCM) 14.3% HIGHER; today announced that it received a letter dated April 8, 2010, proposing to acquire all of the outstanding ordinary shares of the Company, including ordinary shares outstanding in the form of American Depositary Shares, in a transaction under Cayman Islands law that would result in the Company becoming a privately-held company.
Raser Technologies, Inc. (NYSE: RZ) 12.9% LOWER; filed a prospectus supplement under which it may sell shares of its common stock having an aggregate offering price of up to $25 million, from time to time, through a Controlled Equity Offeringsm, or “at-the-market,” program.
Forest Labs (NYSE: FRX) 11.8% LOWER; after an FDA panel voted in favor of both the effectiveness and safety of Forest Labs’ Daxas, the panel voted 10-5 against recommending for approval. While the stock was downgraded at Lazard and Piper Jaffray, two firms also defending the stock, saying buy on weakness